Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lomas

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Vox Sanguinis|December 17, 2008
Alloanti-c in a c-positive, JAL-positive patientJ Ong, P S Walker, E Schmulbach, et al.
Immunohematology|October 28, 2009
RHD deletion in a patient with chronic myeloid leukemiaA Murdock, D Assip, K Hue-Roye, et al.
Vox Sanguinis|January 1, 1990
A low-incidence red cell antigen JAL associated with two unusual Rh gene complexesC Lomas, J Poole, N Salaru, et al.
Immunohematology|October 28, 2009
Molecular studies of DO alleles reveal that JO is more prevalent than HY in Brazil, whereas HY is more prevalent in New YorkL Castilho, W Baleotti, E Tossas, et al.
Transfusion|January 14, 1998
Involvement of Gly96 in the formation of the Rh26 epitopeB H Faas, P C Ligthart, C Lomas-Francis, et al.
Physiology & Behavior|December 16, 2014
Paternal line multigenerational passage of altered risk assessment behavior in female but not male rat offspring of mothers fed a low protein dietL A Reyes-Castro, G L Rodríguez-González, R Chavira, et al.
Clinical Chemistry|December 16, 2025
Improving Recognition of Secondary Hemophagocytic Lymphohistiocytosis (HLH) through a Ferritin-Based Automated Alert: An Interrupted Time Series AnalysisJack W Goodall, Thomas G Nadin, Bethan S Lloyd Jones, et al.
Vox Sanguinis|January 1, 1995
Expression of the erythrocyte antigen Henshaw (He; MNS6): serological and immunochemical studiesM E Reid, C Lomas-Francis, G L Daniels, et al.
Transfusion Medicine (Oxford, England)|October 8, 1997
DBT: a partial D phenotype associated with the low-incidence antigen Rh32M Wallace, C Lomas-Francis, E Beckers, et al.
Vox Sanguinis|January 1, 1995
Blood group terminology 1995. ISBT Working Party on terminology for red cell surface antigensG L Daniels, D J Anstee, J P Cartron, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Vox Sanguinis|December 17, 2008
Alloanti-c in a c-positive, JAL-positive patientJ Ong, P S Walker, E Schmulbach, et al.
Immunohematology|October 28, 2009
RHD deletion in a patient with chronic myeloid leukemiaA Murdock, D Assip, K Hue-Roye, et al.
Vox Sanguinis|January 1, 1990
A low-incidence red cell antigen JAL associated with two unusual Rh gene complexesC Lomas, J Poole, N Salaru, et al.
Immunohematology|October 28, 2009
Molecular studies of DO alleles reveal that JO is more prevalent than HY in Brazil, whereas HY is more prevalent in New YorkL Castilho, W Baleotti, E Tossas, et al.
Transfusion|January 14, 1998
Involvement of Gly96 in the formation of the Rh26 epitopeB H Faas, P C Ligthart, C Lomas-Francis, et al.
Physiology & Behavior|December 16, 2014
Paternal line multigenerational passage of altered risk assessment behavior in female but not male rat offspring of mothers fed a low protein dietL A Reyes-Castro, G L Rodríguez-González, R Chavira, et al.
Clinical Chemistry|December 16, 2025
Improving Recognition of Secondary Hemophagocytic Lymphohistiocytosis (HLH) through a Ferritin-Based Automated Alert: An Interrupted Time Series AnalysisJack W Goodall, Thomas G Nadin, Bethan S Lloyd Jones, et al.
Vox Sanguinis|January 1, 1995
Expression of the erythrocyte antigen Henshaw (He; MNS6): serological and immunochemical studiesM E Reid, C Lomas-Francis, G L Daniels, et al.
Transfusion Medicine (Oxford, England)|October 8, 1997
DBT: a partial D phenotype associated with the low-incidence antigen Rh32M Wallace, C Lomas-Francis, E Beckers, et al.
Vox Sanguinis|January 1, 1995
Blood group terminology 1995. ISBT Working Party on terminology for red cell surface antigensG L Daniels, D J Anstee, J P Cartron, et al.
Pageof 9